Chemoinformaics analysis of (16R)-ent-kauran-16,19-diol
Molecular Weight | 306.49 | nRot | 1 |
Heavy Atom Molecular Weight | 272.218 | nRig | 19 |
Exact Molecular Weight | 306.256 | nRing | 4 |
Solubility: LogS | -3.392 | nHRing | 0 |
Solubility: LogP | 3.952 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 57.675 |
nHD | 2 | BPOL | 34.109 |
QED | 0.764 |
Synth | 5.663 |
Natural Product Likeliness | 3.331 |
NR-PPAR-gamma | 0.007 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.019 |
Pgp-sub | 0 |
HIA | 0.006 |
CACO-2 | -4.858 |
MDCK | 0.0000165 |
BBB | 0.441 |
PPB | 0.936077 |
VDSS | 1.414 |
FU | 0.0486872 |
CYP1A2-inh | 0.02 |
CYP1A2-sub | 0.494 |
CYP2c19-inh | 0.033 |
CYP2c19-sub | 0.907 |
CYP2c9-inh | 0.108 |
CYP2c9-sub | 0.16 |
CYP2d6-inh | 0.052 |
CYP2d6-sub | 0.404 |
CYP3a4-inh | 0.51 |
CYP3a4-sub | 0.186 |
CL | 15.268 |
T12 | 0.165 |
hERG | 0.021 |
Ames | 0.016 |
ROA | 0.033 |
SkinSen | 0.11 |
Carcinogencity | 0.036 |
EI | 0.145 |
Respiratory | 0.857 |
NR-Aromatase | 0.789 |
Antiviral | No |
Prediction | 0.663593 |